REGENXBIO, Inc. (RGNX)

8.80 +0.27 (+3.17%) USD  |  NASDAQ  |  Apr 06, 16:00
8.79 -0.01 (-0.11%) After-Hours: 20:00
More

REGENXBIO SG&A Expense (TTM) : 82.86M for Dec. 31, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for RGNX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Sarepta Therapeutics, Inc. 491.72M
AbbVie, Inc. 14.01B
Krystal Biotech, Inc. 146.91M
Replimune Group, Inc. 103.07M
Ocugen, Inc. 27.58M